The increasing use of anticoagulant and antiplatelet agents has made the management of these medications during and around the time of endoscopy for GI bleeding
Anticoagulants
Anticoagulants
How to Manage Anticoagulants and Antiplatelets During Endoscopic Procedures
How to Manage Anticoagulants and Antiplatelets During Endoscopic Procedures
Rivaroxaban Again Shown to Cause More GI Bleeding Than Other Direct Oral Anticoagulants
Rivaroxaban Again Shown to Cause More GI Bleeding Than Other Direct Oral Anticoagulants
In a study from Iceland, investigators compared GI bleeding rates among 3217 patients receiving rivaroxaban, 2157 receiving apixaban, and 494 receiving dabigatran. Patients were excluded
